1-2 of 2
Kirsten Achilles Poon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

An Anti–CLL-1 Antibody–Drug Conjugate for the Treatment of Acute Myeloid Leukemia

Bing Zheng, Shang-Fan Yu, Geoffrey del Rosario, Steven R. Leong, Genee Y. Lee, Rajesh Vij, Cecilia Chiu, Wei-Ching Liang, Yan Wu, Cecile Chalouni, Jack Sadowsky, Vanessa Clark, Angela Hendricks, Kirsten Achilles Poon, Wayne Chu, Thomas Pillow, Melissa M. Schutten, John Flygare, Andrew G. Polson
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (4): 1358–1368.
https://doi.org/10.1158/1078-0432.CCR-18-0333
Published: 15 February 2019
View article titled, An Anti–CLL-1 Antibody–Drug Conjugate for the Treatment of Acute Myeloid Leukemia
Open the PDF for An Anti–CLL-1 Antibody–Drug Conjugate for the Treatment of Acute Myeloid Leukemia in another window
Includes: Supplementary data
Journal Articles

Abstract POSTER-THER-1441: Biomarker evaluation of phase 1 clinical trials of antibody-drug conjugates (ADCs) in platinum resistant ovarian cancer

Yulei Wang, Ron Firestein, Lisa Ryner, Walter Darbonne, Yinghui Guan, Shan Lu, YJ Choi, Yuanyuan Xiao, Paul Polakis, Becky Suttmann, Rupal Desai, Ling Fu, Ola Saad, Kirsten Achilles Poon, Mitch Denker, Vincent Leveque, Teiko Sumiyoshi, Mark Lackner, David Shames, Eric Humke, Daniel Mayslar
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (16_Supplement): POSTER-THER-1441.
https://doi.org/10.1158/1557-3265.OVCASYMP14-POSTER-THER-1441
Published: 15 August 2015
View article titled, Abstract POSTER-THER-1441: Biomarker evaluation of phase 1 clinical trials of antibody-drug conjugates (ADCs) in platinum resistant ovarian cancer